Pralatrexate: a novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses.

Hui, John; Przespo, Eugene; Elefante, Anjana

Hui, John; Przespo, Eugene; Elefante, Anjana.

Affiliation

Hui J; Department of Pharmacy, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. hhui@med.miami.edu

J Oncol Pharm Pract ; 18(2): 275-83, 2012 Jun.

Article in En | MEDLINE | ID: mdl-21956523

Subject(s)

Aminopterin/analogs & derivatives; Folic Acid Antagonists/therapeutic use; Lymphoma, T-Cell, Peripheral/drug therapy; Neoplasm Recurrence, Local/prevention & control; Aminopterin/pharmacokinetics; Aminopterin/therapeutic use; Animals; Clinical Trials as Topic/methods; Folic Acid Antagonists/pharmacokinetics; Humans; Lymphoma, T-Cell, Peripheral/epidemiology; Lymphoma, T-Cell, Peripheral/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell, Peripheral / Folic Acid Antagonists / Aminopterin / Neoplasm Recurrence, Local Limits: Animals / Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2012 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google